Atika Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Buy
2022
Q3
Sell
2022
Q2
$1.97M Buy
2020
Q1
Sell
2019
Q4
$3.23M Hold
2019
Q3
$2.03M Buy